» Authors » Stephen C Strother

Stephen C Strother

Explore the profile of Stephen C Strother including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 126
Citations 2226
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazurka R, Harkness K, Hassel S, Stensson N, Nogovitsyn N, Poppenk J, et al.
Transl Psychiatry . 2024 Oct; 14(1):431. PMID: 39394160
Evidence from preclinical animal models suggests that the stress-buffering function of the endocannabinoid (eCB) system may help protect against stress-related reductions in hippocampal volume, as is documented in major depressive...
2.
Fu C, Antoniades M, Erus G, Garcia J, Fan Y, Arnone D, et al.
Nat Ment Health . 2024 Jul; 2(2):164-176. PMID: 38948238
Major depressive disorder (MDD) is a heterogeneous clinical syndrome with widespread subtle neuroanatomical correlates. Our objective was to identify the neuroanatomical dimensions that characterize MDD and predict treatment response to...
3.
van der Wijk G, Zamyadi M, Bray S, Hassel S, Arnott S, Frey B, et al.
eNeuro . 2024 Jun; 11(6). PMID: 38830756
Clinical studies of major depression (MD) generally focus on group effects, yet interindividual differences in brain function are increasingly recognized as important and may even impact effect sizes related to...
4.
Ayyash S, Davis A, Alders G, MacQueen G, Strother S, Hassel S, et al.
IBRO Neurosci Rep . 2024 Jan; 16:135-146. PMID: 38293679
Neural network-level changes underlying symptom remission in major depressive disorder (MDD) are often studied from a single perspective. Multimodal approaches to assess neuropsychiatric disorders are evolving, as they offer richer...
5.
Nogovitsyn N, Ballester P, Lasby M, Dunlop K, Ceniti A, Squires S, et al.
J Affect Disord . 2024 Jan; 351:631-640. PMID: 38290583
We examine structural brain characteristics across three diagnostic categories: at risk for serious mental illness; first-presenting episode and recurrent major depressive disorder (MDD). We investigate whether the three diagnostic groups...
6.
Vaccarino S, Wang S, Rizvi S, Lou W, Hassel S, Macqueen G, et al.
BJPsych Open . 2024 Jan; 10(1):e18. PMID: 38179598
Background: Identifying neuroimaging biomarkers of antidepressant response may help guide treatment decisions and advance precision medicine. Aims: To examine the relationship between anhedonia and functional neurocircuitry in key reward processing...
7.
Mazurka R, Cunningham S, Hassel S, Foster J, Nogovitsyn N, Fiori L, et al.
Eur Neuropsychopharmacol . 2023 Dec; 78:71-80. PMID: 38128154
Preclinical research implicates stress-induced upregulation of the enzyme, serum- and glucocorticoid-regulated kinase 1 (SGK1), in reduced hippocampal volume. In the current study, we tested the hypothesis that greater SGK1 mRNA...
8.
Ozzoude M, Varriano B, Beaton D, Ramirez J, Adamo S, Holmes M, et al.
Alzheimers Res Ther . 2023 Jun; 15(1):114. PMID: 37340319
Background: Neuropsychiatric symptoms (NPS) are a core feature of most neurodegenerative and cerebrovascular diseases. White matter hyperintensities and brain atrophy have been implicated in NPS. We aimed to investigate the...
9.
Behan B, Jeanson F, Cheema H, Eng D, Khimji F, Vaccarino A, et al.
Front Neuroinform . 2023 Jun; 17:1158378. PMID: 37274750
The effective sharing of health research data within the healthcare ecosystem can have tremendous impact on the advancement of disease understanding, prevention, treatment, and monitoring. By combining and reusing health...
10.
Riek H, Brien D, Coe B, Huang J, Perkins J, Yep R, et al.
Brain Commun . 2023 Mar; 5(2):fcad049. PMID: 36970045
Oculomotor tasks generate a potential wealth of behavioural biomarkers for neurodegenerative diseases. Overlap between oculomotor and disease-impaired circuitry reveals the location and severity of disease processes via saccade parameters measured...